PhD, Molecular Pharmacology
University of Wolverhampton, Wolverhampton, United Kingdom
MSc, Biomedical Sciences
Nottingham Trent University, Nottingham, United Kingdom
BPharm
Mangalore University, Konaje, India
Vijay D'Souza has over 8 years of experience in primary and secondary research on reimbursement and strategic market access, encompassing target product profile evaluation, landscape assessments, and early access strategies. His background in respiratory research and translational clinical trials has led to multiple publications in peer-reviewed journals. He has worked across a diverse range of therapeutic areas, such as lung diseases, oncology, ophthalmology, cardiovascular disorders, autoimmune diseases, rare genetic disorders, and medical devices. In his current role at RTI-HS, Vijay develops HEOR strategic plans, provides strategic and technical advisory support, conducts HTA appraisal reviews, creates value dossiers, and performs literature reviews. He is a member of a RTI-HS team evaluating innovative research technologies with AI capabilities for application in our market access activities.